Royal Bank Of Canada Forma Therapeutics Holdings, Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $340,848 - $968,929	-47,872 Reduced 96.43%	1,770 $36,000
Q2 2022 Aug 15, 2022	BUY	$5.1 - $10.0 $242,535 - $475,560	47,556 Added 2279.77%	49,642 $342,000
Q1 2022 May 16, 2022	SELL	$8.34 - $14.69 $37,163 - $65,458	-4,456 Reduced 68.11%	2,086 $19,000
Q4 2021 Feb 14, 2022	BUY	$13.6 - $24.89 $37,685 - $68,970	2,771 Added 73.48%	6,542 $93,000
Q3 2021 Nov 15, 2021	SELL	$21.22 - $25.7 $1.19 Million - $1.44 Million	-56,058 Reduced 93.7%	3,771 $88,000
Q2 2021 Aug 16, 2021	BUY	$22.86 - $30.95 $1.37 Million - $1.85 Million	59,829 New	59,829 $1.49 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.